BSG and ischemia: This contributes to secondary damage after ischemia via the breakdown of the blood–brain barrier and the recruitment of peripheral leukocytes into the brain; the administration of CD147-blocking antibody after ischemia thus leads to neuroprotection (Jin et al., 2017; Patrizz et al., 2020).